- $1.52bn
- $1.86bn
- $560.56m
- 89
- 92
- 29
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 535 | 691 | 296 | 454 | 561 |
Cost of Revenue | |||||
Gross Profit | 269 | 468 | 126 | 195 | 319 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 396 | 377 | 296 | 380 | 367 |
Operating Profit | 139 | 314 | 0.202 | 74.2 | 193 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 73.8 | 267 | -11.1 | 62.6 | 162 |
Provision for Income Taxes | |||||
Net Income After Taxes | 73.7 | 266 | -11.5 | 62 | 161 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 73.7 | 266 | -11.5 | 61.5 | 161 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 73.7 | 266 | -11.5 | 61.5 | 161 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.438 | 1.64 | -0.126 | 0.256 | 0.994 |
Dividends per Share |